Keyphrases
Potential Therapeutics
100%
C-Myc
100%
Colorectal Cancer
100%
Dihydroartemisinin
100%
Growth Inhibition
18%
Therapeutic Target
18%
MYC Protein
18%
Early-onset Colorectal Cancer (EOCRC)
18%
Therapeutic Strategies
9%
Cancer Cells
9%
Cell Proliferation
9%
Protein Degradation
9%
Transcriptional Activity
9%
Induced Apoptosis
9%
Proliferation Apoptosis
9%
Respiration
9%
Mouse Model
9%
High-level Expression
9%
Colorectal Cancer Cells
9%
Lipidomics
9%
ATP Production
9%
Pharmacological Data
9%
Clinical Samples
9%
Fatty Acid Synthase
9%
Metabolic Phenotype
9%
Oxygen Consumption
9%
Cancer Cell Viability
9%
Cancer Stage
9%
Frontline Treatment
9%
Molecular Differences
9%
Acetyl-CoA Carboxylase
9%
Treatment Change
9%
Medium-chain acyl-CoA Dehydrogenase
9%
Oncogenic Drivers
9%
Biochemistry, Genetics and Molecular Biology
Oncogene C Myc
100%
Cancer Cell
50%
Myc Protein
50%
Mouse Model
25%
Cell Proliferation
25%
Protein Catabolism
25%
Programmed Cell Death
25%
Adenosine Triphosphate
25%
Cell Viability
25%
Oxygen Consumption
25%
Lipidomics
25%
Fatty Acid Synthase
25%
Cancer Staging
25%
Medium-Chain Acyl-CoA Dehydrogenase
25%
Acetyl-CoA Carboxylase
25%
Acyl-CoA
25%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Dihydroartemisinin
100%
Malignant Neoplasm
14%
Myc Protein
14%
Mouse Model
7%
Cell Viability
7%
Adenosine Triphosphate
7%
Cancer Staging
7%
Fatty Acid Synthase
7%
Acetyl-CoA
7%
Carboxylase
7%
Acyl Coenzyme A Dehydrogenase
7%